|
71
|
244
|
5l5rB |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
69
|
250
|
5l5rA |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
68
|
242
|
5l5bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
59
|
195
|
5l5iJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
67
|
233
|
5l5jM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
63
|
241
|
5l54G |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
64
|
241
|
5l5wG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
59
|
196
|
5laiN |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
65
|
240
|
5lajC |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
59
|
204
|
5laiI |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
67
|
242
|
5lajD |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
71
|
240
|
5laiC |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
69
|
244
|
5l62B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
66
|
250
|
5l66A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
68
|
242
|
5laiD |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
60
|
196
|
5l6aN |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
61
|
195
|
5laiJ |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
57
|
204
|
5l6bI |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
63
|
241
|
5laiG |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
57
|
204
|
5l66I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
59
|
226
|
5laiH |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
45
|
236
|
5m32F |
Human 26s proteasome in complex with oprozomib |
|
71
|
240
|
5l65C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
58
|
226
|
5lajH |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
67
|
250
|
5l55A |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
69
|
250
|
5laiA |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
66
|
231
|
5l5bE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
64
|
241
|
5l52G |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
70
|
244
|
5l55B |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
69
|
212
|
5lajK |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
75
|
212
|
5l55K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
59
|
195
|
5l5dJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
66
|
231
|
5l5aE |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
69
|
250
|
5lajA |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
67
|
244
|
5laiB |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
67
|
240
|
5l67C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
250
|
5l54A |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
71
|
243
|
5laiF |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
195
|
5lajJ |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
69
|
228
|
5lajM |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
211
|
5m2bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
61
|
222
|
5laiL |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
70
|
233
|
5laiM |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
68
|
211
|
5laiK |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
231
|
5l52E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
64
|
242
|
5l54D |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
70
|
243
|
5l6cF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
64
|
241
|
5l6aG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
196
|
5l65N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
240
|
5l66C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
